Dentatorubral-Pallidoluysian Atrophy Natural History and Biomarkers Study (DRPLA NHBS)
This is a prospective, limited collection of retrospective information, longitudinal, multi-national, multi-center study, observational, confirmed DRPLA-mutation carrier and a volunteer control group.
Department Chairs | NYU Langone Health
The leadership of NYU Langone Health includes our renowned department chairs, each one an exemplary in their field.
Depression | NYU Langone Health
NYU Langone mental health specialists diagnose and manage depression.
Depression treatment and A dynamics: A study of Alzheimer s disease risk (ABD Study)
The study will use a randomized 8-week double-blind placebo controlled parallel trial using escitalopram to test the associations between depressive symptoms (captured by the MADRS and other depression scales), and AD biomarkers in both CSF and plasma as well as changes in vascular dysfunction (VD)-associated biomarkers(MMP2, MMP9, homocysteine, and platelet activation markers P-selectin and GP IIa/IIIb). The primary endpoints are the severity of depression symptoms at baseline, the change in depression scores after treatment with escitalopram, and the associated changes in AD and VD markers peptide levels. Secondary endpoints are depression severity at baseline, which will be tested in regression models in relation to the AD biomarkers (Aß peptides in CSF) cross-sectionally at baseline and after antidepressant treatment to test that Aß peptides are correlated with symptoms. The study will also examine if decreased levels of VD-associated biomarkers will (at least partially) mediate the effect of depression treatment response on increases in CSF Aß levels. This proposal will be the first to explore the relationships between CSF AD and VD biomarker levels and MDD symptom severity in cognitively normal MDD patients and the direction of causation between changes in Aß and VD biomarkers and changes in MDD symptom severity. The results of this study, if successful, may provide a rationale for reducing AD risk through a more effective treatment of depression in the elderly.
Dermatologist Doctors | NYU Langone Health
View all NYU Langone doctors who specialize in dermatology.
Dermatology | NYU Langone Health
NYU Langone dermatologists provide a variety of services, including medical, surgical, pediatric, and cosmetic dermatology.
Dermatology Clinical Studies Unit | NYU Langone Health
NYU Langone’s Dermatology Clinical Studies Unit conducts clinical trials of treatments for disorders of the skin, hair, and nails.
Dermatomyositis | NYU Langone Health
Doctors at NYU Langone diagnose dermatomyositis, a rare skin and muscle condition, and prescribe medication and physical therapy to manage it.
Development of digital biomarkers and advanced data analytics in neurosurgery
Development of a neurosurgical disease digital biomarkers' signature to help to diagnose, monitor, manage and predict disease course
Developmental Delays in Children | NYU Langone Health
Specialists at Hassenfeld Children’s Hospital at NYU Langone diagnose and provide care for children with developmental delays.